IRDAI has asked insurance companies to provide comprehensive coverage for intending parents and surrogate mothers undergoing surrogacy and fertility treatments.
“An insurance coverage of such amount as may be prescribed for a period of 12 months in favour of the oocyte donor by the commissioning couple or woman from an insurance company or an agent recognised by the IRDAI,” the regulator said.
According to the IRDAI, the intending woman or couple can purchase a general health insurance coverage in favour of surrogate mother for a period of 36 months from an insurance company.
The recent circular from IRDAI is a positive step towards providing comprehensive coverage for intending parents and surrogate mothers.”
The IRDAI directive is expected to ensure that all parties involved in the surrogacy process are protected from any unforeseen medical complications that may arise during the pregnancy and post-partum period, insurance officials said.
